STAA Q4 2025 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$58M+18.1% YoY

Gross Profit

$44M75.7% margin

Operating Income

-$23M-39.5% margin

Net Income

-$18M-31.7% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-39.0%

Cash Flow

Operating Cash Flow

-$3,914

Free Cash Flow

-$3,914

Stock-Based Comp.

$8,613

Balance Sheet

Total Assets

$452M

Total Liabilities

$107M

Stockholders' Equity

$344,184

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$49M	+18.1%
Gross Profit	$44M	$32M	+38.2%
Operating Income	-$23M	-$28M	+18.2%
Net Income	-$18M	-$34M	+46.5%